[go: up one dir, main page]

UA36043A - Method for treating fetoplacental insufficiency - Google Patents

Method for treating fetoplacental insufficiency

Info

Publication number
UA36043A
UA36043A UA99105859A UA99105859A UA36043A UA 36043 A UA36043 A UA 36043A UA 99105859 A UA99105859 A UA 99105859A UA 99105859 A UA99105859 A UA 99105859A UA 36043 A UA36043 A UA 36043A
Authority
UA
Ukraine
Prior art keywords
fetoplacental insufficiency
treating
insufficiency
treating fetoplacental
actovegin
Prior art date
Application number
UA99105859A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Юрій Петрович Вдовиченко
Юрий Петрович Вдовиченко
Дмитро Ростаславович Шадлун
Тамара Григорівна Романенко
Тамара Григорьевна Романенко
Генадій Петрович Кияшко
Геннадий Петрович Кияшко
Ігор Леонідович Пирля
Игорь Леонидович Пирля
Ілля Сергійович Глазков
Илья Сергеевич Глазков
Original Assignee
Київська Медична Академія Післядипломної Освіти Ім. П.Л. Щупика
КИЕВСКАЯ МЕДИЦИНСКАЯ АКАДЕМИЯ ПОСЛЕДИПЛОМНОГО ОБРАЗОВАНИЯ ИМ. П.Л.Шупика
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Київська Медична Академія Післядипломної Освіти Ім. П.Л. Щупика, КИЕВСКАЯ МЕДИЦИНСКАЯ АКАДЕМИЯ ПОСЛЕДИПЛОМНОГО ОБРАЗОВАНИЯ ИМ. П.Л.Шупика filed Critical Київська Медична Академія Післядипломної Освіти Ім. П.Л. Щупика
Priority to UA99105859A priority Critical patent/UA36043A/en
Publication of UA36043A publication Critical patent/UA36043A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the medicine. The conventional complex therapy of the fetoplacental insufficiency is used. In addition, Actovegin is administered intravenously dropwise, 5 mL in 5% glucose solution in a total volume of 300-400 mL once in 1-3 days, 4-5 infusions in the course depending on the severity of the disease.
UA99105859A 1999-10-27 1999-10-27 Method for treating fetoplacental insufficiency UA36043A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA99105859A UA36043A (en) 1999-10-27 1999-10-27 Method for treating fetoplacental insufficiency

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA99105859A UA36043A (en) 1999-10-27 1999-10-27 Method for treating fetoplacental insufficiency

Publications (1)

Publication Number Publication Date
UA36043A true UA36043A (en) 2001-04-16

Family

ID=74182321

Family Applications (1)

Application Number Title Priority Date Filing Date
UA99105859A UA36043A (en) 1999-10-27 1999-10-27 Method for treating fetoplacental insufficiency

Country Status (1)

Country Link
UA (1) UA36043A (en)

Similar Documents

Publication Publication Date Title
CA2114014A1 (en) Advanced Drug Delivery System and Method of Treating Psychiatric, Neurological and Other Disorders with Carbamazepine
IL133585A0 (en) Soluble prodrugs of paclitaxel
EP1019072A4 (en) Method for assisting in differential diagnosis and treatment of autistic syndromes
EP0740650A4 (en) Codrugs as a method of controlled drug delivery
AU6586896A (en) Fatty acid treatment
MXPA03007374A (en) Methods of treating diabetes mellitus.
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
ITMI931714A1 (en) USE OF TAXOL FOR THE PRODUCTION OF A MEDICATION FOR THE TREATMENT OF CANCER FORMS
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
HK1037142A1 (en) Phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate for the treatment of neoplastic diseases
BG106171A (en) Compositions and uses of et743 for treating cancer
MY125984A (en) Pharmaceutical solutions of levosimendan.
MX9302038A (en) METHOD FOR THE TREATMENT OF CANCER BY A JOINT THERAPY WITH 2-HALOMETILIDENO DERIVATIVES AND A SPECIFIC PHASE M OR PHASE S ANTINEOPLASIC AGENT.
EA200400548A1 (en) TREATMENT OF HEAVY PNEUMONIA THROUGH THE INTRODUCTION OF THE TISSUE FACTOR INHIBITOR (TFPI)
DE69821498D1 (en) USE OF AMIFOSTIN
UA36043A (en) Method for treating fetoplacental insufficiency
AU3308099A (en) Method for the treatment of pain, including chronic and female specific pain
IT1254331B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF THE SHOCK, PARTICULARLY OF THE CARDIOGEN SHOCK AND SEPTIC SHOCK.
UA10301A (en) Method for treatment of stomach cancer
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
TR200000728T2 (en) The use of IFN-alpha and amantadine in the treatment of chronic hepatitis C.
UA29106A (en) The method for treatment of vibration disease
MD1854F1 (en) Method of treatment in the congestive cardiac insufficiency
AU2444695A (en) Use of intravenously administered iron in the therapy of tumoral and infectious diseases
UA38996A (en) Method for treating chronic pancreatitis with concomitant ischemic heart disease in patients of old age